Skip Navigation


JAC Advance Access originally published online on May 19, 2009
Journal of Antimicrobial Chemotherapy 2009 64(1):84-87; doi:10.1093/jac/dkp170
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
64/1/84    most recent
dkp170v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Guimarães, E. T.
Right arrow Articles by Soares, M. B. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guimarães, E. T.
Right arrow Articles by Soares, M. B. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis

Elisalva T. Guimarães1, Milena S. Lima1, Luana A. Santos1, Ivone M. Ribeiro2, Therezinha B. C. Tomassini2, Ricardo Ribeiro dos Santos1,3, Washington L. C. dos Santos1 and Milena B. P. Soares1,3,*

1 Centro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brazil 2 FarManguinhos, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil 3 Hospital São Rafael, Salvador, BA, Brazil

Received 29 January 2009; returned 8 March 2009; revised 8 April 2009; accepted 16 April 2009

* Corresponding author. Centro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz, Rua Waldemar Falcão, 121 Candeal, Salvador, BA 40296-710, Brazil. Tel: +55-71-3176-2260; Fax: +55-71-3176-2272; E-mail: milenabpsoares{at}gmail.com

Objectives: We have previously demonstrated the immunomodulatory effects of physalins, secosteroids purified from Physalis angulata. Here we investigate the antileishmanial activity of physalins in vitro and in vivo in a model of cutaneous leishmaniasis.

Methods: The antileishmanial activity of physalins B, D and F was tested in Leishmania-infected macrophage cultures. For the in vivo studies, BALB/c mice were infected with Leishmania amazonensis subcutaneously in the ear pinna and treated with physalin F by topical administration.

Results: Physalins B and F were able to reduce the percentage of Leishmania-infected macrophages and the intracellular parasite number in vitro at concentrations non-cytotoxic to macrophages. More importantly, topical treatment with physalin F significantly reduced the lesion size, the parasite load and histopathological alterations in BALB/c mice infected with L. amazonensis.

Conclusions: Our results demonstrate the potent antileishmanial activity of physalins, especially physalin F, and suggest these molecules as the basis for the development of new therapeutic options for cutaneous leishmaniasis.

Keywords: infections , macrophages , mice , secosteroids , therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.